How Centralized Fulfillment is Making Pharmacy More Efficient
Drug Topics
NOVEMBER 25, 2024
Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.
Sat.Nov 23, 2024 - Fri.Nov 29, 2024
98 
IVIG Demonstrates Effectiveness in Several Neuroimmune Conditions, Indicating Potential for Long COVID Treatment
Pharmacy Times
NOVEMBER 23, 2024
Intravenous immunoglobulin (IVIG) has proven efficacy in autoimmune neuropathies, with mixed but promising outcomes in severe COVID-19 cases and post-acute sequelae of SARS-CoV-2 infection trials.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Mount Sinai opens doors to new $100M research site for AI development
Fierce Healthcare
NOVEMBER 26, 2024
Mount Sinai Health System has opened the doors of its new AI research center in Manhattan, the Hamilton and Amabel James Center for AI and Human Health. | Mount Sinai Health System announced on Tuesday that it opened its Hamilton and Amabel James Center for Artificial Intelligence and Human Health, which will be a research site for AI development.
Digital transformation expected to shorten drug development timelines
Pharmaceutical Technology
NOVEMBER 27, 2024
Pharmaceutical professionals expect digital solutions to solve drug development headaches, with AI already proving disruptive.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Q&A: A Closer Look at the Current State of Biosimilars in the Drug Market
Drug Topics
NOVEMBER 28, 2024
Steve Callahan, Senior Director of Advisory & Insights at MMIT, sat down with Drug Topics to discuss industry trends behind biosimilars.
Aprocitentan: A New Hope in Resistant Hypertension Management
Pharmacy Times
NOVEMBER 27, 2024
In trials, blood pressure reductions were maintained over extended periods, suggesting that the drug could offer a sustained effect.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
ASH: Incyte's Monjuvi triumphs in follicular lymphoma phase 3, teeing up FDA filing
Fierce Pharma
NOVEMBER 25, 2024
Incyte’s previously disclosed phase 3 win in relapsed or refract | In the phase 3 inMIND study, Monjuvi—added to Bristol Myers Squibb's Revlimid and Roche's Rituxan—triggered a 57% reduction in the risk of disease progression, relapse or death in R/R FL patients compared with those who were treated with placebo, Revlimid and Rituxan.
GLP-1 receptor agonists aid broader outcomes in kidney disease, major analysis finds
European Pharmaceutical Review
NOVEMBER 26, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists have shown to provide meaningful benefits in chronic kidney disease (CKD) and individuals with and without diabetes. This based on the largest, most comprehensive analysis of GLP-1 antagonists on kidney and cardiovascular outcomes. While GLP-1 receptor agonists have shown benefit for type 2 diabetes, obesity and cardiovascular disease, its impact as a treatment in chronic kidney disease is not as clear, the researchers explained.
Consequences of the Change Healthcare Cyberattack Continue
Pharmacy Times
NOVEMBER 29, 2024
Legislative efforts regarding cybersecurity are ongoing, but individuals and organizations should remain vigilant.
Biden proposes Medicare, Medicaid cover anti-obesity drugs
Fierce Healthcare
NOVEMBER 26, 2024
The Centers for Medicare & Medicaid Services (CMS) is attempting to cover anti-obesity medications under Medicare Part D and Medicaid, the agency announced Nov. 26. | With time running out before leaving office, the Biden administration is proposing a rule to have Medicare and Medicaid cover anti-obesity medications and bolster guardrails for AI, among the changes.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Bristol Myers Squibb hands pink slips to 195 workers in NJ as cost-cutting effort rolls on
Fierce Pharma
NOVEMBER 25, 2024
Bristol Myers Squibb has executed another round of layoffs in its ongoing cost-savings push. | Bristol Myers Squibb has executed another round of layoffs in its ongoing cost-savings push. The company has handed pink slips to 195 more employees, according to a New Jersey Worker Adjustment and Retraining Notification (WARN) update.
Transforming pharmacovigilance: The revolutionary impact of generative AI on drug safety
pharmaphorum
NOVEMBER 26, 2024
Discover the revolutionary impact of generative artificial intelligence (GenAI) on drug safety in pharmacovigilance. Learn how this cutting-edge technology is transforming the industry.
FDA Approves Methylene Blue Injection for Acquired Methemoglobinemia
Pharmacy Times
NOVEMBER 27, 2024
Methemoglobinemia is a blood disorder that affects proper release of oxygen around the body.
Cambridge Health Alliance taps Abridge's AI medical scribe to support multilingual patients
Fierce Healthcare
NOVEMBER 26, 2024
Providers are rapidly adopting generative AI-based clinical documentation tools to aid clinicians and make digital paperwork more efficient. | Cambridge Health Alliance, the only public academic health system in Massachusetts, is deploying Abridge's AI-based medical note-taking tool across its 600 clinicians after a successful pilot.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: It might be now or never for the BIOSECURE Act
STAT
NOVEMBER 27, 2024
WASHINGTON — Legislation targeting Chinese biotechnology companies caused a ruckus early this year. None of that may matter if Congress doesn’t pass it in December. The BIOSECURE Act would restrict U.S. pharmaceutical and biotechnology companies from doing business with certain Chinese companies, including WuXi AppTec and WuXi Biologics.
Moderna’s missteps spotlight PMCPA’s role in upholding pharma ethics
pharmaphorum
NOVEMBER 26, 2024
Moderna's missteps serve as a reminder of the importance of regulatory bodies like PMCPA in upholding ethics within the pharmaceutical industry. Learn more about their role and impact.
Empowering Diabetes Care: The Evolving Role of Pharmacists
Pharmacy Times
NOVEMBER 27, 2024
Pharmacists are well-positioned to address diabetes from a multifaceted approach.
UnitedHealthcare wins 2025 star ratings lawsuit requiring CMS to recalculate results
Fierce Healthcare
NOVEMBER 25, 2024
UnitedHealthcare successfully won its lawsuit over the Centers for Medicare and Medicaid Services, a federal judge determined Nov. 22. | UnitedHealthcare will get to claim victory over CMS for its star ratings lawsuit win. The insurer will receive a recalculated score from the federal agency, potentially giving the insurer more in quality bonus payments.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
4 vitamins for post-COVID fatigue
The Checkup by Singlecare
NOVEMBER 26, 2024
When you’re sick with a viral infection, you expect to feel poorly for a few days. COVID is no exception. Whether you’re hit with respiratory, GI, or flu-like symptoms such as muscle pain, headache, and fatigue, testing positive for COVID means being down for the count for a bit before returning to your daily routine. However, what if you don’t bounce back, even after you’re technically recovered?
Part One: Overcoming challenges and seizing opportunities in global market access for rare and complex conditions
pharmaphorum
NOVEMBER 29, 2024
Part One: Overcoming challenges and seizing opportunities in global market access for rare and complex conditions Mike.
PBM Price Negotiations Have Unintended Consequences for Independent Pharmacies
Pharmacy Times
NOVEMBER 27, 2024
However, pharmacists can help mitigate these effects.
OCR missed opportunities to prevent health information breaches: HHS watchdog
Fierce Healthcare
NOVEMBER 25, 2024
HHS' Office of the Inspector General released a report on Monday that badgers the Office for Civil Rights' enforcement of HIPAA.
Q&A: Pharmacist on Medication Developments for People Living with HIV
Drug Topics
NOVEMBER 29, 2024
Jay Holloway, PharmD, AAHIVP, Pharmacist with the AIDS Healthcare Foundation, discussed the ongoing developments impacting patients with HIV and their prescription drugs.
Medigene axes staff and refocuses its TCR pipeline
pharmaphorum
NOVEMBER 26, 2024
Medigene slashes staff and delays trials of its lead TCR therapy candidate as it refocuses its pipeline.
FDA Approves Oral Liquid Solution of Imatinib for Certain Forms of Leukemia and Other Cancers
Pharmacy Times
NOVEMBER 25, 2024
This is the first oral liquid form of imatinib (Imkeldi; Shorla Oncology) to be approved to treat cancers.
EMA launches ESMP for better management of drug shortages in EU
Pharmaceutical Technology
NOVEMBER 29, 2024
The ESMP platform enables marketing authorisation holders to report shortages and will be mandatory from 2025.
COVID-19 Roundup: Importance of Vaccine Uptake in Winter, Obesity’s Link with Long COVID
Drug Topics
NOVEMBER 29, 2024
Catch up on important COVID-19 news from November 2024.
UK government commits to first men's health strategy
pharmaphorum
NOVEMBER 29, 2024
UK government commits to first men's health strategy Phil.
FDA Approves Landiolol For Treatment of Supraventricular Tachycardia
Pharmacy Times
NOVEMBER 27, 2024
The approval is based on clinical studies that demonstrate the management of heart rate with minimal reductions to blood pressure.
UK Government to launch first ever men’s health strategy
Pharmaceutical Technology
NOVEMBER 29, 2024
The government said that men are less likely than women to seek medical help, particularly for mental health issues.
Self-Efficacy Linked with Greater Diabetes Control in Adolescents
Drug Topics
NOVEMBER 27, 2024
A recent study found that there was a significant relationship between self-efficacy for disease control and the level of glycemic control.
STAT+: Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger
STAT
NOVEMBER 26, 2024
Recursion Pharmaceuticals, one of the most advanced companies using artificial intelligence and machine learning tools to expedite drug development , laid off employees after closing a merger last week.
Study Results Show 1 in 20 Adults With RSV Are Hospitalized
Pharmacy Times
NOVEMBER 25, 2024
Findings highlight the unmet medical need for outpatient interventions and preventive measures that can reduce hospitalizations.
Let's personalize your content